216 related articles for article (PubMed ID: 32166646)
1. Concordance of Vancomycin Population-Predicted Pharmacokinetics with Patient-Specific Pharmacokinetics in Adult Hospitalized Patients: A Case Series.
Onor IO; Neuliep A; Tran KA; Lambert J; Gillard CJ; Brakta F; Ezebuenyi MC; St James K; Okogbaa JI; Beyl RA
Drugs R D; 2020 Jun; 20(2):83-93. PubMed ID: 32166646
[TBL] [Abstract][Full Text] [Related]
2. Correlation of aminoglycoside and vancomycin pharmacokinetic parameters.
Wragge TM; Cooper BE
Ann Pharmacother; 1993 Nov; 27(11):1346-8. PubMed ID: 8286806
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin pharmacokinetics in spinal cord injured patients: a comparison with age-matched, able-bodied controls.
Lavezo LA; Davis RL
J Spinal Cord Med; 1995 Oct; 18(4):233-5. PubMed ID: 8591068
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
Adane ED; Herald M; Koura F
Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin Pharmacokinetics in Obese Patients with Sepsis or Septic Shock.
Masich AM; Kalaria SN; Gonzales JP; Heil EL; Tata AL; Claeys KC; Patel D; Gopalakrishnan M
Pharmacotherapy; 2020 Mar; 40(3):211-220. PubMed ID: 31957057
[TBL] [Abstract][Full Text] [Related]
6. Augmented Renal Clearance Using Population-Based Pharmacokinetic Modeling in Critically Ill Pediatric Patients.
Avedissian SN; Bradley E; Zhang D; Bradley JS; Nazer LH; Tran TM; Nguyen A; Le J
Pediatr Crit Care Med; 2017 Sep; 18(9):e388-e394. PubMed ID: 28640009
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Capping Creatinine Clearance on Achieving Therapeutic Vancomycin Concentrations in Neurocritically Ill Patients with Traumatic Brain Injury.
Nelson NR; Morbitzer KA; Jordan JD; Rhoney DH
Neurocrit Care; 2019 Feb; 30(1):126-131. PubMed ID: 30051194
[TBL] [Abstract][Full Text] [Related]
8. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
Hermida J; Tutor JC
Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin Pharmacokinetic Parameters in Patients with Hemorrhagic Stroke.
Morbitzer KA; Jordan JD; Sullivan KA; Durr EA; Olm-Shipman CM; Rhoney DH
Neurocrit Care; 2016 Oct; 25(2):250-7. PubMed ID: 26942732
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the accuracy of a pharmacokinetic dosing program in predicting serum vancomycin concentrations in critically ill patients.
Aubron C; Corallo CE; Nunn MO; Dooley MJ; Cheng AC
Ann Pharmacother; 2011 Oct; 45(10):1193-8. PubMed ID: 21896920
[TBL] [Abstract][Full Text] [Related]
11. Dosing of vancomycin in patients with continuous-flow left ventricular assist devices: a clinical pharmacokinetic analysis.
Jennings DL; Makowski CT; Chambers RM; Lanfear DE
Int J Artif Organs; 2014 Mar; 37(3):270-4. PubMed ID: 24619894
[TBL] [Abstract][Full Text] [Related]
12. Clearance of vancomycin during continuous infusion in Intensive Care Unit patients: correlation with measured and estimated creatinine clearance and serum cystatin C.
Kees MG; Hilpert JW; Gnewuch C; Kees F; Voegeler S
Int J Antimicrob Agents; 2010 Dec; 36(6):545-8. PubMed ID: 20863668
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software.
Nunn MO; Corallo CE; Aubron C; Poole S; Dooley MJ; Cheng AC
Ann Pharmacother; 2011 Jun; 45(6):757-63. PubMed ID: 21652786
[TBL] [Abstract][Full Text] [Related]
14. Creatinine-clearance estimates for predicting gentamicin pharmacokinetic values in obese patients.
Leader WG; Tsubaki T; Chandler MH
Am J Hosp Pharm; 1994 Sep; 51(17):2125-30. PubMed ID: 7985687
[TBL] [Abstract][Full Text] [Related]
15. Optimization of an empiric vancomycin dosing algorithm for improved target concentration attainment in patients with thermal injury.
Hill DM; Velamuri SR; Lanfranco J; Romero Legro I; Sinclair SE; Hickerson WL
Burns; 2019 Mar; 45(2):423-432. PubMed ID: 30340863
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Vancomycin Prediction Methods Based on Estimated Creatinine Clearance or Trough Levels.
Haeseker M; Croes S; Neef C; Bruggeman C; Stolk L; Verbon A
Ther Drug Monit; 2016 Feb; 38(1):120-6. PubMed ID: 26418699
[TBL] [Abstract][Full Text] [Related]
17. Systemic inflammatory response syndrome criteria and vancomycin dose requirement in patients with sepsis.
Shimamoto Y; Fukuda T; Tanaka K; Komori K; Sadamitsu D
Intensive Care Med; 2013 Jul; 39(7):1247-52. PubMed ID: 23604132
[TBL] [Abstract][Full Text] [Related]
18. Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique.
Vance-Bryan K; Guay DR; Gilliland SS; Rodvold KA; Rotschafer JC
Antimicrob Agents Chemother; 1993 Mar; 37(3):436-40. PubMed ID: 8460912
[TBL] [Abstract][Full Text] [Related]
19. Comparison of vancomycin pharmacokinetics in hospitalized elderly and young patients using a Bayesian forecaster.
Guay DR; Vance-Bryan K; Gilliland S; Rodvold K; Rotschafer J
J Clin Pharmacol; 1993 Oct; 33(10):918-22. PubMed ID: 8227461
[TBL] [Abstract][Full Text] [Related]
20. An assessment of vancomycin pharmacokinetic variability in pediatric cardiology patients.
Marlowe KF; Chicella MF; Claridge TE; Pittman SW
J Pediatr Pharmacol Ther; 2003 Apr; 8(2):132-6. PubMed ID: 23300400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]